Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 36.73% vs 4.15% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 13.49% vs 16.22% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 55.93% vs 40.67% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 29.94% vs 21.74% in Mar 2025
Compare Profit and Loss Results of Medico Remedies
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
206.00
85.00
121.00
142.35%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
206.00
85.00
121.00
142.35%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
-6.00
5.00
83.33%
Raw Materials Consumed
153.00
42.00
111.00
264.29%
Power & Fuel Cost
3.00
2.00
1.00
50.00%
Employee Cost
7.00
15.00
-8.00
-53.33%
Operating Expenses
11.00
4.00
7.00
175.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
8.00
1.00
7.00
700.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
6.00
-5.00
-83.33%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
189.00
70.00
119.00
170.00%
Operating Profit (PBDIT) excl Other Income
17.00
15.00
2.00
13.33%
Other Income
5.00
9.00
-4.00
-44.44%
Operating Profit (PBDIT)
22.00
25.00
-3.00
-12.00%
Interest
1.00
0.00
1.00
0%
Profit before Depriciation and Tax
21.00
24.00
-3.00
-12.50%
Depreciation
3.00
2.00
1.00
50.00%
Profit Before Taxation & Exceptional Items
18.00
22.00
-4.00
-18.18%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
18.00
23.00
-5.00
-21.74%
Provision for Tax
4.00
6.00
-2.00
-33.33%
Profit After Tax
13.00
16.00
-3.00
-18.75%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
42.00
170.00
-128.00
-75.29%
Profit Available for appropriations
55.00
187.00
-132.00
-70.59%
Appropriations
55.00
187.00
-132.00
-70.59%
Equity Dividend (%)
0%
20%
-20.00
Earnings Per Share
1.58
45.85
-44.27
-96.55%
Profit And Loss - Net Sales
Net Sales 206.38 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 36.73% vs 4.15% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 17.03 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 13.49% vs 16.22% in Mar 2025
Profit And Loss - Interest
Interest 1.81 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 55.93% vs 40.67% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 13.12 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 29.94% vs 21.74% in Mar 2025
